NEW DELHI: Days after India’s drug regulator suspended manufacturing and marketing permission of Mumbai-based ETOD Pharmaceuticals, which had claimed that their new eye drop reduced dependency on reading glasses for those suffering from presbyopia, an age-related vision condition, on Thursday clarified that it is a “therapeutic option, available only by prescription from the registered medical practitioner.” This paper was the …
